SMTL ID : 5iug.1

Crystal Structure of Anaplastic Lymphoma Kinase (ALK) in complex with 5a

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.93 Å

Oligo State

monomer

Ligands

1 x 729: N-[3-(4-{[(5-tert-butyl-1,2-oxazol-3-yl)carbamoyl]amino}-3-methylphenyl)-1H-pyrazol-5-yl]-4-[(4-methylpiperazin-1-yl)methyl]benzamide(Non-covalent)

729.1: 23 residues within 4Å: Chain A: L.39, V.47, A.65, E.84, I.88, F.91, I.96, V.97, L.113, E.114, L.115, M.116, A.117, G.118, G.119, E.127, F.162, H.164, L.173, I.185, G.186, D.187, F.188 17 PLIP interactions: 17 interactions with chain A Hydrophobic interactions: A:V.47, A:I.88, A:F.91, A:I.96, A:F.162, A:F.162, A:L.173, A:D.187, A:F.188, A:F.188 Hydrogen bonds: A:E.84, A:E.84, A:M.116, A:M.116, A:M.116, A:D.187 Salt bridges: A:E.127

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Tu, C.H. et al., Pyrazolylamine Derivatives Reveal the Conformational Switching between Type I and Type II Binding Modes of Anaplastic Lymphoma Kinase (ALK). J.Med.Chem. (2016)

Release Date

2016-05-18

Peptides

ALK tyrosine kinase receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

ALK tyrosine kinase receptor

Related Entries With Identical Sequence